Sanofi

ISIN US80105N1054

WKN 662283

Market cap (in EUR)

94,938 m

Country

France

Sector

Healthcare

Dividend yield

3.47%

Overview

Quote

Description

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Show more Show less

Healthcare Biopharmaceuticals Other Biopharmaceuticals France

Chart

Financials

Key metrics

Market capitalisation, EUR	94,938 m
EPS, EUR	-
P/B ratio	1.3
P/E ratio	19.1
Dividend yield	3.47%

Income statement (2025)

Revenue, EUR	43,643 m
Net income, EUR	4,941 m
Profit margin	11.32%

What ETF is Sanofi in?

There are 4 ETFs which contain Sanofi. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sanofi is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
First Trust Value Line® Dividend Index UCITS ETF Acc	0.45%	Equity United States Dividend	6
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.95%	Equity United States Health Care Biotech	45
iShares Nasdaq US Biotechnology UCITS ETF	0.95%	Equity United States Health Care Biotech	692
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	0.58%	Equity United States Technology	35

Performance

Returns overview

YTD	-4.55%
1 month	-5.39%
3 months	+0.09%
6 months	-10.41%
1 year	-16.92%
3 years	-
5 years	-
Since inception (MAX)	-9.54%
2025	-6.87%
2024	-0.74%
2023	-
2022	-

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).